Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,896.00p
   
  • Change Today:
      19.00p
  • 52 Week High: 2,120.00p
  • 52 Week Low: 1,722.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 350,964
  • Market Cap: £4,206.97m
  • RiskGrade: 125

Hikma Pharmaceuticals director buys-in after full-year results

By Alexander Bueso

Date: Thursday 14 Mar 2019

LONDON (ShareCast) - (Sharecast News) - One of Hikma Pharmaceuticals's directors picked-up some shares in the company the day after its latest full-year numbers.
On Thursday, Dr. Pamela Kirby, a non-executive director at the non-branded generic and in-licensed pharmaceutical products maker, purchased 1,500 shares, on the market, at 1,586p apiece for a total transaction amount of £23,790.

The day before, Hikma had posted a 7% increase in full-year 2018 core revenues to $2.08bn with core operating profit up by 19% at $460m, but its sales were 1% below the average analyst forecast and profit was 2% light.

Core basic earnings per share, however, increased 31% to 137.8 cents, beating the consensus by 2% due to lower finance charges, while cash-flow from operating activities of $430m down from $443m.

Her purchase followed others by the executive chairman and vice-chairman, Said Darwazah and Mazen Darwazah, respectively, also the day before.

Analysts at Numis described the company's results as "strong" but said consensus estimates might be set for "modest downgrades".

"The shares aren't particularly cheap and conditions in US generics remain volatile and with the shares trading on 11 times's EV/EBITDA we stick with the 'hold' rating."

Top Director Buys

Hikma Pharmaceuticals (HIK)
Director name: Kirby,Pamela
Amount purchased: 1,500 @ 1,586.00p
Value: £23,790.00

4d Pharma (DDDD)
Director name: Stevenson,Alexander James
Amount purchased: 24,896 @ 91.50p
Value: £22,779.84

Haydale Graphene Industries (HAYD)
Director name: Humm,Roger James
Amount purchased: 841,432 @ 2.00p
Value: £16,828.64

Haydale Graphene Industries (HAYD)
Director name: Broadbent,Keith
Amount purchased: 500,000 @ 2.00p
Value: £10,000.00

Haydale Graphene Industries (HAYD)
Director name: Banks,David
Amount purchased: 500,000 @ 2.00p
Value: £10,000.00

Haydale Graphene Industries (HAYD)
Director name: Redman-Thomas,Laura
Amount purchased: 375,000 @ 2.00p
Value: £7,500.00

4d Pharma (DDDD)
Director name: Peyton,Duncan Joseph
Amount purchased: 6,770 @ 92.00p
Value: £6,228.40

React Group (REAT)
Director name: Joyce,Michael
Amount purchased: 2,000,000 @ 0.27p
Value: £5,340.00

React Group (REAT)
Director name: Joyce,Michael
Amount purchased: 1,000,000 @ 0.27p
Value: £2,670.00

Kcom Group (KCOM)
Director name: Bielby,Anna
Amount purchased: 217 @ 69.18p
Value: £150.12

Zotefoams (ZTF)
Director name: Stirling,David
Amount purchased: 25 @ 599.00p
Value: £149.75

Zotefoams (ZTF)
Director name: McGrath ,Gary
Amount purchased: 25 @ 599.00p
Value: £149.75



Top Director Sells

Record (REC)
Director name: Wood-Collins,James
Amount sold: 146,716 @ 28.70p
Value: £42,107.49

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,896.00p
Change Today 19.00p
% Change 1.01 %
52 Week High 2,120.00p
52 Week Low 1,722.00p
Volume 350,964
Shares Issued 221.89m
Market Cap £4,206.97m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.84% below the market average43.84% below the market average43.84% below the market average43.84% below the market average43.84% below the market average
6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average
Price Trend
19.79% above the market average19.79% above the market average19.79% above the market average19.79% above the market average19.79% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income
16.04% above the market average16.04% above the market average16.04% above the market average16.04% above the market average16.04% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
28.67% below the market average28.67% below the market average28.67% below the market average28.67% below the market average28.67% below the market average
3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 15-Aug-24 21-Mar-24
Paid 20-Sep-24 03-May-24
Amount 32.00¢ 47.00¢

Trades for 27-Sep-2024

Time Volume / Share Price
17:19 146,027 @ 1,882.00p
16:53 411 @ 1,896.00p
16:53 2,246 @ 1,896.00p
16:35 266 @ 1,896.00p
16:35 153,088 @ 1,896.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page